Oncology studies present unique challenges when it comes to participant treatment, resupply, and study management.

Innate Pharma has gained breakthrough therapy designation for lacutamab to treat adults with relapsed or refractory Sézary ...

Two of Bambusa’s bispecific antibody candidates for immunological and inflammatory disorders are set to enter the clinic in ...

Bavarian Nordic sets up a bout with Valneva’s Ixchiq, the former’s Vimkunya already having an edge in population reach.

Moderna has reported revenue of $1bn for the fourth quarter (Q4) of 2024, a sharp decline from $2.8bn in the same quarter in ...

Given the number of comorbidities associated with obesity, the market's growth will impact the entire cardiometabolic disease ...

Nemluvio, which was also approved for prurigo nodularis, becomes Galderma’s first approved biologic in its dermatology ...

Bio-Thera Solutions has signed an exclusive licence and commercialisation agreement with Intas Pharmaceuticals for BAT2506 in ...

New EU regulations aim to speed up health technology assessments (HTAs), but the pharma industry raises logistical concerns.

The World Health Organization and St Jude Children's Research Hospital have kicked off a programme to distribute cancer ...

A study led by UCL found that individuals with rare diseases were five times more likely to die from Covid-19 than the ...

Newleos has closed an oversubscribed Series A financing round, raising $93.5m to revolutionise neuropsychiatric disorder ...